QURE
Price
$30.34
Change
+$0.22 (+0.73%)
Updated
Nov 13 closing price
Capitalization
1.89B
108 days until earnings call
Intraday BUY SELL Signals
SXTP
Price
$1.17
Change
-$0.06 (-4.88%)
Updated
Nov 13 closing price
Capitalization
4.76M
Intraday BUY SELL Signals
Interact to see
Advertisement

QURE vs SXTP

Header iconQURE vs SXTP Comparison
Open Charts QURE vs SXTPBanner chart's image
uniQure
Price$30.34
Change+$0.22 (+0.73%)
Volume$2.19M
Capitalization1.89B
60 Degrees Pharmaceuticals
Price$1.17
Change-$0.06 (-4.88%)
Volume$51.74K
Capitalization4.76M
QURE vs SXTP Comparison Chart in %
QURE
Daily Signal:
Gain/Loss:
SXTP
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
QURE vs. SXTP commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QURE is a Hold and SXTP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (QURE: $30.12 vs. SXTP: $1.23)
Brand notoriety: QURE and SXTP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QURE: 70% vs. SXTP: 14%
Market capitalization -- QURE: $1.89B vs. SXTP: $4.76M
QURE [@Biotechnology] is valued at $1.89B. SXTP’s [@Biotechnology] market capitalization is $4.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QURE’s FA Score shows that 0 FA rating(s) are green whileSXTP’s FA Score has 0 green FA rating(s).

  • QURE’s FA Score: 0 green, 5 red.
  • SXTP’s FA Score: 0 green, 5 red.
According to our system of comparison, both QURE and SXTP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QURE’s TA Score shows that 5 TA indicator(s) are bullish while SXTP’s TA Score has 4 bullish TA indicator(s).

  • QURE’s TA Score: 5 bullish, 5 bearish.
  • SXTP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, QURE is a better buy in the short-term than SXTP.

Price Growth

QURE (@Biotechnology) experienced а +15.58% price change this week, while SXTP (@Biotechnology) price change was -5.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

QURE is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($1.89B) has a higher market cap than SXTP($4.76M). QURE YTD gains are higher at: 70.555 vs. SXTP (-80.930). SXTP has higher annual earnings (EBITDA): -7.75M vs. QURE (-119.56M). QURE has more cash in the bank: 377M vs. SXTP (1.97M). SXTP has less debt than QURE: SXTP (154K) vs QURE (66.7M). QURE has higher revenues than SXTP: QURE (14.3M) vs SXTP (641K).
QURESXTPQURE / SXTP
Capitalization1.89B4.76M39,698%
EBITDA-119.56M-7.75M1,543%
Gain YTD70.555-80.930-87%
P/E RatioN/A16.57-
Revenue14.3M641K2,231%
Total Cash377M1.97M19,166%
Total Debt66.7M154K43,312%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
QURESXTP
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 18 days ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
QURE
Daily Signal:
Gain/Loss:
SXTP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGADX47.891.62
+3.50%
Franklin Gold and Precious Metals Adv
EISIX31.910.22
+0.69%
Carillon ClariVest Intl Stock I
WFMDX49.620.12
+0.24%
Allspring Special Mid Cap Value Admin
SPFFX32.450.04
+0.12%
Sphere 500 Climate R6
MOINX26.32-0.03
-0.11%
NYLI WMC Small Companies Investor Class

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with NEVPF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
-2.33%
NEVPF - QURE
50%
Loosely correlated
N/A
AXON - QURE
42%
Loosely correlated
-0.47%
LXEO - QURE
40%
Loosely correlated
+0.99%
MLTX - QURE
37%
Loosely correlated
+8.68%
SNGX - QURE
36%
Loosely correlated
-4.23%
More

SXTP and

Correlation & Price change

A.I.dvisor tells us that SXTP and KROS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and KROS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTP
1D Price
Change %
SXTP100%
-3.15%
KROS - SXTP
24%
Poorly correlated
+3.37%
CLDX - SXTP
23%
Poorly correlated
-0.49%
ABSI - SXTP
22%
Poorly correlated
-1.45%
SPHRF - SXTP
21%
Poorly correlated
N/A
QURE - SXTP
21%
Poorly correlated
-2.33%
More